SEARCH RESULTS FOR: "Tag: NASDAQ-EXEL"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2018(3)
CATEGORIES
Buzz Stocks(1)
Quantitative Analysis(2)
Technical Analysis(2)

5/10/2018 10:19 AM
Exelixis, Inc. (NASDAQ:EXEL) stock is down 11.8% to trade at $19.13 this morning, after the biotech company's colorectal cancer drug that was tested in combination with Roche's Tecentriq failed late-...
2/23/2018 1:18 PM
ImmunoGen, Inc. (NASDAQ:IMGN) shares have been on a tear in 2018, advancing more than 75% already this year. What's more, IMGN stock could have room to run, if recent history is any indicator. Meanwhi...
1/19/2018 2:48 PM
The shares of biotech Exelixis, Inc. (NASDAQ:EXEL) -- which makes Cabometyx -- have been in a channel of higher highs and lows since early 2016, gaining 55% over the past year. Since its most recent...
PEOPLE ALSO SEARCH FOR

Partnercenter